SJS Investment Consulting’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SJS Investment Consulting's LLY Position: Q3 2026 in Review
SJS Investment Consulting increased its Eli Lilly (LLY) stake by 0.35% in Q3 2026, buying an estimated $79.1K and bringing the position to 19,220 shares worth $22.2M. The position accounts for 2.24% of the portfolio, ranked #5.
SJS Investment Consulting first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $23M in Q2 2026. 1,901 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- SJS Investment Consulting held 19,220 shares of Eli Lilly worth $22.2M as of Q3 2026.
- SJS Investment Consulting bought 67 Eli Lilly shares in Q3 2026, an estimated $79.1K.
- Eli Lilly made up 2.24% of SJS Investment Consulting's portfolio in Q3 2026, its #5 holding.
- SJS Investment Consulting first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- SJS Investment Consulting's Eli Lilly position peaked at $23M in Q2 2026.
- 1,901 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.